Phio Pharmaceuticals (PHIO) EBIT Margin (QoQ) (2012 - 2018)
Phio Pharmaceuticals (PHIO) EBIT Margin (QoQ) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 65,659.00 |
| Jun 30, 2018 | 646,064.00 |
| Mar 31, 2018 | 353,855.00 |
| Jun 30, 2016 | -216,111.00 |
| Mar 31, 2015 | 780,672.00 |
| Dec 31, 2014 | -266,518.00 |
| Sep 30, 2014 | 303,542.00 |
| Jun 30, 2014 | -894,511.00 |
| Mar 31, 2014 | 78,621.00 |
| Dec 31, 2013 | -643,167.00 |
| Sep 30, 2013 | -137,775.00 |
| Jun 30, 2013 | 2.63 Mn |
| Mar 31, 2013 | -2.29 Mn |
| Dec 31, 2012 | -130,456.00 |